United Therapeutics Corporation (NASDAQ:UTHR) Q3 2025 Earnings Call Transcript October 29, 2025
United Therapeutics Corporation beats earnings expectations. Reported EPS is $7.16, expectations were $6.89.
Operator: Good morning, everyone, and welcome to the United Therapeutics Corporation Third Quarter 2025 Corporate Update. My name is Jamie, and I will be your conference operator today. [Operator Instructions] Please also note today’s event is being recorded. At this time, I’d like to turn...
